教員別検索
所属別検索
学位論文・関西医大誌
学術雑誌掲載論文
著書
学会発表
（最終更新日：2026-09-11 10:54:23）
ハシモト ダイスケ
HASHIMOTO DAISUKE
橋本 大輔
所属
医学部胆膵外科学講座
職種
准教授
■
学術雑誌掲載論文
1.
原著(症例報告除く)
Conversion surgery for unresectable pancreatic ductal adenocarcinoma with liver metastasis at initial diagnosis: a nationwide multicenter study. 2026/09
2.
原著(症例報告除く)
Duke Pancreatic Monoclonal Antigen Type 2 for Monitoring Carbohydrate Antigen 19-9 Nonexpressor Pancreatic Cancer. 2026/08
3.
原著(症例報告除く)
Neoadjuvant and adjuvant treatment for pancreatic ductal adenocarcinoma in patients over 80 years old based on a nationwide clinical database. 2026/07
4.
原著(症例報告除く)
Survival Impact of Pathological Residual Patterns for Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy. 2026/06
5.
原著(症例報告除く)
Effect of Double Layer Polyglycolic Acid Felt for Reducing Pancreatic Fistula After Pancreatoduodenectomy: Results of a Multicenter Randomized Control Trial (PLANET-PJ trial). 2026/03
6.
原著(症例報告除く)
Emergency Cholecystectomy in Patients Classified as High Risk According to the Tokyo Guidelines 2018: A Real-World Analysis 2026/03
7.
原著(症例報告除く)
Survival Impact After Resection for Postoperative Recurrence or Metastasis of Pancreatic Ductal Adenocarcinoma Analyzed Using a Time-Dependent Cox Regression Model. 2026/03
8.
原著(症例報告除く)
Value of Intraoperative Pancreatoscopy in Patients Undergoing Resection for Main-Duct Intraductal Papillary Mucinous Neoplasm: Thirty-Day Follow-Up of a Prospective International Study. 2026/01
9.
その他
治療法の再整理とアップデートのために 専門家による私の治療 膵神経内分泌腫瘍(pNET) 2026/01
10.
症例報告
Solid Pseudopapillary Neoplasm of the Pancreas Showing Spontaneous Regression Followed by Regrowth: A Case Report. 2026
11.
原著(症例報告除く)
Long-term outcomes of prophylactic right-half dissection of the superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic ductal adenocarcinoma: five-year results from a randomized phase II trial. 2025/11
12.
その他
Liquid biopsies for risk stratification of intraductal papillary mucinous neoplasms. 2025/10
13.
その他
Defining oligo-recurrence criteria for locoregional intervention in pancreatic ductal adenocarcinoma: A multidisciplinary era perspective. 2025/09
14.
原著(症例報告除く)
Favorable Response Defined by CA19-9 Reduction After Neoadjuvant Treatment for Pancreatic Cancer. 2025/09
15.
その他
Call for participation in a multicenter study: Intraoperative blood loss - Towards a standardized and objective recording method. 2025/08
16.
原著(症例報告除く)
Fecal Bifidobacterium Serves as a Predictor of Postoperative Recurrence After Neoadjuvant Chemotherapy in Pancreatic Cancer. 2025/08
17.
原著(症例報告除く)
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study. 2025/07
18.
その他
【よくわかる膵体尾部切除術】脾温存膵体尾部切除術 低侵襲手術時代における開腹脾温存膵体尾部切除術 2025/07
19.
原著(症例報告除く)
A history of gastrectomy is a risk factor for choledocholithiasis in patients undergoing cholecystectomy: A single center retrospective study. 2025/05
20.
原著(症例報告除く)
The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study 2025/05
21.
その他
【肝腫瘍の外科治療戦略(肝細胞癌・肝内胆管癌・大腸癌肝転移以外)】転移性肝腫瘍 膵癌肝転移に対する外科的治療戦略 2025/05
22.
原著(症例報告除く)
膵切除術における外科的アプローチ別の収支損益分析 2025/05
23.
原著(症例報告除く)
Clinical role of intraperitoneal chemotherapy in patients with pancreatic ductal adenocarcinoma concomitant with occult peritoneal dissemination: A multicenter retrospective study 2025/03
24.
その他
胆嚢腺扁平上皮癌10例の臨床病理学的検討 2025/03
25.
その他
Author's reply: Exploring the role of neoadjuvant therapy for resectable pancreatic cancer 2025/02
26.
その他
Building an international network of young surgeons across surgical specialties - Introducing the Young Surgeons Publications Committee 2025/02
27.
原著(症例報告除く)
Neoadjuvant Treatment with Changes in Chemotherapy Regimens According to Carbohydrate Antigen 19-9 Level for Resectable/Borderline Resectable Pancreatic Ductal Adenocarcinoma 2025/01
28.
総説
膵癌に対するconversion surgeryの現状と将来展望 2025/01
29.
原著(症例報告除く)
膵原発のpure hepatoid carcinomaの1例 2024/12
30.
原著(症例報告除く)
Preoperative CA19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: A further plea for biological resectability criteria 2024/10
31.
原著(症例報告除く)
The efficacy of wrapping with polyglycolic acid mesh and fibrin glue in preventing clinically relevant pancreatic fistula after minimally invasive distal pancreatectomy (WRAP Study): study protocol for a multicenter randomized controlled trial in Japan 2024/10
32.
その他
【胆膵手術のちょっとしたコツ】膵癌術前審査腹腔鏡をどう行う?【動画付】 2024/10
33.
原著(症例報告除く)
Impact of endoscopic ultrasound-guided tissue acquisition on prognosis and peritoneal lavage cytology in resectable or borderline resectable pancreatic ductal adenocarcinoma 2024/08
34.
原著(症例報告除く)
Conversion surgery for BRCA-mutated pancreatic ductal adenocarcinoma with liver metastasis treated with platinum-based chemotherapy followed by olaparib 2024/07
35.
原著(症例報告除く)
Factors affecting nonfunctioning small pancreatic neuroendocrine neoplasms and proposed new treatment strategies 2024/07
36.
その他
【肝胆膵癌に対する集学的治療の新潮流】膵癌 BR膵癌に対する集学的治療の展望 2024/07
37.
原著(症例報告除く)
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 2024/06
38.
その他
【75歳以上高齢者胆膵疾患の病態と高齢者機能評価による治療戦略】高齢者膵癌患者における外科治療 2024/05
39.
原著(症例報告除く)
Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma? 2024/03
40.
原著(症例報告除く)
Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study 2024/03
41.
原著(症例報告除く)
Central pancreatectomy might be an acceptable surgical procedure for clinical T1 pancreatic body ductal adenocarcinoma: A multicenter retrospective analysis 2023/12
42.
原著(症例報告除く)
Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study 2023/12
43.
原著(症例報告除く)
The degree of satisfaction and level of learning in male and female surgical residents: a nationwide questionnaire survey of graduating residents in Japan 2023/11
44.
その他
【膵癌取扱い規約第8版～変更の要点～】CYに関する変更点 2023/10
45.
原著(症例報告除く)
"Conversion surgery" for locally advanced pancreatic cancer: A position paper by the study group at the joint meeting of the International Association of Pancreatology (IAP) & Japan Pancreas Society (JPS) 2022 2023/09
46.
総説
Is surgical resection justified for pancreatic ductal adenocarcinoma with distant abdominal organ metastasis? A position paper by experts in pancreatic surgery at the Joint Meeting of the International Association of Pancreatology (IAP) & the Japan Pancreas Society (JPS) 2022 in Kyoto 2023/09
47.
原著(症例報告除く)
Standard versus delayed initiation of S-1 adjuvant chemotherapy after surgery for pancreatic cancer: a secondary analysis of a nationwide cohort by the Japan Pancreas Society 2023/08
48.
原著(症例報告除く)
Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma 2023/06
49.
原著(症例報告除く)
A Retrospective Study Investigating the Safety and Efficacy of Nanoliposomal Irinotecan in Elderly Patients with Unresectable Pancreatic Cancer 2023/05
50.
その他
【外科手術と感染症】肝胆膵外科 膵頭十二指腸切除術における周術期感染症対策 2023/04
51.
その他
Academic value and impact of continuous global academic learning: the International HPB surgery journal club concept 2023/03
52.
原著(症例報告除く)
The academic impact and value of an international online surgery lecture series 2023/02
53.
総説
【膵癌Conversion Surgeryへの挑戦】遠隔転移膵癌に対するConversion Surgeryの現状と展望 2023/02
54.
原著(症例報告除く)
Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail 2023/01
55.
その他
【新・外科感染症診療ハンドブック】総論 COVID-19パンデミックと外科 国際共同研究の結果から 2022/12
56.
原著(症例報告除く)
Estimation of the degree of surgical difficulty anticipated for pancreatoduodenectomy: Preoperative and intraoperative factors 2022/11
57.
原著(症例報告除く)
Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy 2022/11
58.
原著(症例報告除く)
Outcomes of gynecologic cancer surgery during the COVID-19 pandemic: an international, multicenter, prospective CovidSurg-Gynecologic Oncology Cancer study 2022/11
59.
原著(症例報告除く)
Risk factors and treatment strategy for clinical hepatico-jejunostomy stenosis defined with intrahepatic bile duct dilatation after pancreaticoduodenectomy: A retrospective study 2022/11
60.
その他
【術前画像の読み解きガイド-的確な術式選択と解剖把握のために】膵臓 膵嚢胞性腫瘍(IPMN, MCN, SCN, SPN) 術式選択のポイント 2022/10
61.
その他
FOCUS クラウドファンディングで研究資金を集める! 臨床研究(先進医療制度を利用した特定研究)から得た経験 2022/06
62.
原著(症例報告除く)
High tumor budding predicts a poor prognosis in resected duodenal adenocarcinoma 2022/06
63.
原著(症例報告除く)
Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group 2022/06
64.
総説
【肝胆膵癌におけるconversion therapy】膵癌におけるconversion therapy 膵01研究から得られた課題とconversion surgeryの現状 2022/05
65.
原著(症例報告除く)
Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit 2022/03
66.
原著(症例報告除く)
胆嚢腫瘍を形成したBリンパ芽球性白血病の1例 2022/03
67.
原著(症例報告除く)
A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma. 2022/02
68.
原著(症例報告除く)
Efficacy of active hexose correlated compound on survival of patients with resectable/borderline resectable pancreatic cancer: a study protocol for a double-blind randomized phase II study 2022/02
69.
原著(症例報告除く)
Randomized phase III trial of intravenous and intraperitoneal paclitaxel with S-1 versus gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma with peritoneal metastasis (SP study) 2022/02
70.
原著(症例報告除く)
Validation of the triple-checked criteria for drain management after pancreatectomy. 2022/02
71.
原著(症例報告除く)
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. 2022/01
72.
その他
【conversion surgeryのすべて 切除不能を切除可能に!】切除不能膵癌に対するconversion surgery 2021/12
73.
その他
【Conversion surgeryアップデート】がん種別の最新動向 転移性膵癌に対するconversion surgery 2021/12
74.
原著(症例報告除く)
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 2021/11
75.
原著(症例報告除く)
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study. 2021/11
76.
その他
【膵・胆道癌における薬物療法のすべて】がん薬物療法のエビデンス 切除境界膵癌に対する術前治療 2021/11
77.
その他
【膵癌の診断と治療-最新の話題-】コンバージョン手術 2021/11
78.
その他
【Stepごとに要点解説 標準術式アトラス最新版】胆・膵 膵体尾部切除術±脾臓摘出術 2021/10
79.
原著(症例報告除く)
SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study 2021/09
80.
原著(症例報告除く)
Does direct invasion of peripancreatic lymph nodes impact survival in patients with pancreatic ductal adenocarcinoma? A retrospective dual-center study. 2021/08
81.
原著(症例報告除く)
Hepatic actinomycosis after total pancreatectomy: A case report 2021/08
82.
その他
How to determine the surgical extent in patients with multifocal intraductal papillary mucinous neoplasm? 2021/06
83.
原著(症例報告除く)
Nutritional impact of active hexose-correlated compound for patients with resectable or borderline-resectable pancreatic cancer treated with neoadjuvant therapy 2021/06
84.
原著(症例報告除く)
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study. 2021/06
85.
その他
【膵臓症候群(第3版)-その他の膵臓疾患を含めて-】膵腫瘍 膵癌 膵体尾部癌 2021/06
86.
原著(症例報告除く)
残膵癌に対する残膵全摘の治療成績 膵全摘術との比較検討 2021/06
87.
その他
【消化器癌;診断と治療のすべて】消化器癌の診断・病期分類・治療・成績 膵癌 集学的治療 切除不能膵癌に対する集学的治療 2021/05
88.
原著(症例報告除く)
Conversion surgery in patients with pancreatic cancer and peritoneal metastasis 2021/04
89.
その他
【これだけは知っておきたい胆膵疾患の診断・治療up-to-date】UR膵癌に対するConversion surgery 2021/04
90.
総説
【特別企画(5)地域を守り、地域で生きる外科医たちの思い】 地域一般病院が患者に愛され職員も幸せになれるメソッド 2021/03
91.
その他
【切除可能膵癌に対する標準治療:術前治療の意義】切除可能膵癌に対する術後補助治療 2021/02
92.
原著(症例報告除く)
Pancreatic trauma: proposal for management algorithm 2021
93.
原著(症例報告除く)
Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1 2020/12
94.
原著(症例報告除く)
Is there disparity between regions and facilities in surgical resident training in Japan? Insights from a national survey 2020/12
95.
その他
【膵頭十二指腸切除の完全ガイド-定型術式から困難症例への対処法まで】膵頭十二指腸切除の定型術式 PDの定型術式・ポイント解説 胆管空腸吻合は連続縫合か結節縫合か 2020/12
96.
原著(症例報告除く)
Are graduating residents sufficiently competent? Results of a national gap analysis survey of program directors and graduating residents in Japan 2020/09
97.
原著(症例報告除く)
Multicenter randomized phase II trial of prophylactic right-half dissection of superior mesenteric artery nerve plexus in pancreatoduodenectomy for pancreatic head cancer 2020/09
98.
その他
【胆膵疾患における栄養サポート】膵頭十二指腸切除術後の栄養管理(脂肪肝対策) 2020/07
99.
原著(症例報告除く)
Risk model for severe postoperative complications after total pancreatectomy based on a nationwide clinical database 2020/05
100.
総説
Roles of autophagy and pancreatic secretory trypsin inhibitor in trypsinogen activation in acute pancreatitis 2020/04
101.
原著(症例報告除く)
Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer 2017/04
5件表示
全件表示(101件)
■
著書
1.
部分執筆
Treatment Approach for Pancreatic Cancer with Peritoneal Dissenmination, Management of Pancreatic Cancer and Cholangiocarcinoma 2021
